Merck (NYSE:MRK) has ended acquisition talks with oncology-focused Revolution Medicines. The discussions centered on a ...

Merck (MRK) closed the most recent trading day at $108.34, moving +1.35% from the previous trading session. The stock ...

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Merck & Company Inc (NYSE:MRK) has reportedly ended discussions to acquire Revolution Medicines Inc (NASDAQ:RVMD) after the two sides failed to agree on valuation, according to the Wall Street Journal ...

RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based pharmaceutical giant has completed its $9.2 billion acquisition of Cidara ...

Merck has appointed Benjamin Hein as a new member of its executive board and CEO of the company’s Electronics Business. The company announced on ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Managing Director of the Merck Group in Taiwan, John Lee, said that while Apple's decision to halt its MicroLED development is significant, it might open more doors for MicroLED manufacturers in ...

Looking comfortable in a kurta, Belen Garijo, Chair–Executive Board and Chief Executive Officer of the German Science and Technology Giant Merck Group, smiles whenever India is mentioned. At the ...